 |
 |
This Accredited Continuing Education Product comprises content captured live from the American Diabetes Association 67th Scientific Sessions. This program will allow Diabetes Healthcare Professionals to learn about:
- The gap that exists between current oral hypoglycemic and insulin treatment regimens and the attainment of optimal blood glucose levels
- The effectiveness of aggressive treatment regimens in helping patients obtain their desired glycemic goals, especially with the use of innovative therapeutic treatment options now available
- Methods for clinicians and patients to receive the education needed to properly incorporate an aggressive therapeutic regimen into a daily diabetes care plan.
Each presentation includes synchronized slides and audio as well as a written transcription. Each activity below is accredited by the American Diabetes Association for Physicians, Physician Assistants, Nurses, Nurse Practitioners, Pharmacists, Dieticians, Podiatric Physicians, and Certified Diabetes Educators.
Aging with the Spectre of Diabetes in the 21st Century
Clinical Relevance of the Beta-Cell ATP-dependent Potassium Channel
Diabetes in Children
Effect of Adipose Tissue Dysregulation on Metabolic Homeostasis and Insulin Action
Insulin Initiation in Type 2 Diabetes
Insulin Signaling - Outside, Looking In
Practical Implementation of New Technology
Pros and Cons of GLP Agonists versus DPP IV Inhibitors
Use of Insulin in the Intensive Care Unit - Who? And What are the Targets?
|